Navigation Links
Transfusions increase clot risk in hospitalized cancer patients
Date:11/24/2008

Blood transfusions used to treat anemia in patients with cancer are associated with an increased risk of life-threatening blood clots, at a similar rate as other treatments for cancer-induced anemia, according to scientists at the University of Rochester Medical Center.

These findings, published in Tuesday's Archives of Internal Medicine, pose a quandary for doctors who want to prevent thromboembolism one of the leading causes of illness and death in people with cancer.

"We've known that medications used for the treatment of anemia in cancer cause blood clots and using transfusions was an alternative that some doctors chose to try to avoid this problem. This study shows that transfusions may be no better for patients," says Alok Khorana, M.D., lead author on the study. "We need to be cautious in the use of transfusions and search for ways to reduce our patients' risk of developing blood clots, which are dangerous."

When patients receive chemotherapy, doctors watch closely for signs of anemia, a common side-effect that causes fatigue, dizziness and headaches. To combat the anemia, oncologists prescribe medications known as erythropoiesis-stimulating agents (ESAs), which boost red-blood-cell production.

Recent research has shown that these medications raised patients' risk of developing blood clots and the Food and Drug Administration issued restrictions for use last year. An alternative recommendation is to use red blood cell transfusions.

In this retrospective study, researchers examined the risk of developing blood clots for hospitalized patients who received blood transfusions. Scientists analyzed discharge summaries in the University Health System Consortium which includes information on more than 500,000 people hospitalized at 60 medical centers from 1995-2003.

Khorana and his team studied data on more than 70,500 patients who received a blood transfusion. Among those patients, 7.2 percent developed venous thromboembolism (VTE) and 5.2 percent developed arterial thromboembolism (ATE.) That's significantly higher than the 3.8 percent and 3.1 percent rates, respectively, for other patients in the study who did not receive transfusions. However, the figures are comparable to the data on ESAs.

People with cancer are at risk for developing blood clots in their arms or legs, and occasionally, portions of the blood clot can break off and migrate through the circulatory system to the lungs, a condition called pulmonary embolism, which can be life-threatening. Arterial thrombosis also occurs more frequently in cancer patients than in non-cancer patients. This can manifest as a heart attack or a stroke, and can also be fatal.

The investigators, who were funded by the National Cancer Institute and National Heart, Lung and Blood Institute, focused solely on people who were hospitalized during cancer care. However, a majority of cancer patients receive outpatient care. Scientists expect to study thrombosis risk for that primary group of patients as well, Khorana said.

"We need to understand why people who get transfusions are more likely to get blood clots," said Charles Francis, M.D., professor of Medicine and director of the Hemostasis and Thrombosis program.


'/>"/>

Contact: Leslie White
Leslie_White@urmc.rochester.edu
585-273-1119
University of Rochester Medical Center
Source:Eurekalert

Related medicine news :

1. Controversial Anemia Drug Doesnt Cut Need for Transfusions
2. Study links blood transfusions to surgery complications in women
3. Children with sickle cell disease, silent strokes show some relief with blood transfusions
4. Transfusions of Older Blood Dont Work as Well
5. Fresh Transfusions Improve Odds for Cancer Patients After Surgery
6. Smoking may strongly increase long-term risk of eye disease
7. Diabetes appears to increase risk of death for patients with acute coronary syndromes
8. Prophylactic cranial irradiation in small cell lung cancer significantly increases survival
9. Fat on chest and upper back increases risk of insulin resistance
10. Ability to cope with stress can increase good cholesterol in older white men, study finds
11. Handling Stress Properly Increases Good Cholesterol
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 13, 2017 , ... ProVest Insurance Group, a family managed ... Raleigh regions, is organizing an extended charity drive to benefit the family of ... , After struggling since birth with several health challenges, T.J. was later diagnosed ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The American ... to become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer ... Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. ...
(Date:10/13/2017)... QUEENS, N.Y (PRWEB) , ... October 13, 2017 , ... ... recently became a member of ElderCounsel, a national organization of elder law and special ... constantly changing laws and rules. It also provides a forum to network with elder ...
(Date:10/13/2017)... ... ... Ellevate Network, the leading network for professional women, brought together some of ... their inaugural Summit in New York City in June. The event was livestreamed with ... 3 million. To watch the Mobilize Women video, click here . , ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in agile ... a contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise ... use of Agile methodologies in a consistent and high value manner across CMS ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a ... targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , ...
(Date:9/13/2017)...   OrthoAtlanta has been named the official orthopedic ... (AFHC) for the 2018 College Football Playoff (CFP) National Championship ... Stadium in Atlanta, Georgia . OrthoAtlanta is ... campaign, participating in many activities leading up to, and including ... ...
Breaking Medicine Technology: